Contact-dependent depletion of hydrogen peroxide by catalase is a novel mechanism of myeloid-derived suppressor cell induction operating in human hepatic stellate cells

Journal of Immunology

Volumn 194, Issue 6, 2015, Pages 2578-2586

  Resheq, Yazid J ^a,b   Li, Ka Kit ^a   Ward, Stephen T ^a   Wilhelm, Annika ^a   Garg, Abhilok ^a   Curbishley, Stuart M ^a   Blahova, Miroslava ^a   Zimmermann, Henning W ^a,c   Jitschin, Regina ^b   Mougiakakos, Dimitrios ^b   Mackensen, Andreas ^b   Weston, Chris J ^a   Adams, David H ^a  

^a University of Birmingham   (United Kingdom)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CD14 ANTIGEN; GLYCOPROTEIN GP 91; HLA DR ANTIGEN; HYDROGEN PEROXIDE; HYDROXYLAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; CYBB PROTEIN, HUMAN; MEMBRANE PROTEIN;

ARTICLE; BONE MARROW CELL; CELL METABOLISM; COMPETITIVE INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR MECHANICS; MONOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEPLETION; QUANTITATIVE ANALYSIS; RESPIRATORY BURST; STELLATE CELL; STROMA CELL; SUPPRESSOR CELL; ANTAGONISTS AND INHIBITORS; CELL COMMUNICATION; CELL CULTURE; CELL LINE; COCULTURE; DOSE RESPONSE; DRUG EFFECTS; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANTIGENS, CD14; BLOTTING, WESTERN; CATALASE; CELL COMMUNICATION; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HEPATIC STELLATE CELLS; HLA-DR ANTIGENS; HUMANS; HYDROGEN PEROXIDE; HYDROXYLAMINE; MEMBRANE GLYCOPROTEINS; MONOCYTES; MYELOID CELLS; NADPH OXIDASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84924546322     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401046     Document Type: Article

References (47)

1. Ugel, S., F. Delpozzo, G. Desantis, F. Papalini, F. Simonato, N. Sonda, S. Zilio, and V. Bronte. 2009. Therapeutic targeting of myeloid-derived suppressor cells. Curr. Opin. Pharmacol. 9: 470.481.
2. Ostrand-Rosenberg, S., and P. Sinha. 2009. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182: 4499.4506.
3. Greten, T. F., M. P. Manns, and F. Korangy. 2011. Myeloid derived suppressor cells in human diseases. Int. Immunopharmacol. 11: 802.807.
4. Hoechst, B., L. A. Ormandy, M. Ballmaier, F. Lehner, C. Kr.uger, M. P. Manns, T. F. Greten, and F. Korangy. 2008. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells. Gastroenterology 135: 234.243.
5. Poschke, I., D. Mougiakakos, J. Hansson, G. V. Masucci, and R. Kiessling. 2010. Immature immunosuppressive CD14+HLA-DR./low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res. 70: 4335. 4345.
6. Arihara, F., E. Mizukoshi, M. Kitahara, Y. Takata, K. Arai, T. Yamashita, Y. Nakamoto, and S. Kaneko. 2013. Increase in CD14+HLA-DR./low myeloidderived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis. Cancer Immunol. Immunother. 62: 1421.1430.
7. Bumgardner, G. L., M. Heininger, J. Li, D. Xia, J. Parker-Thornburg, R. M. Ferguson, and C. G. Orosz. 1998. A functional model of hepatocyte transplantation for in vivo immunologic studies. Transplantation 65: 53.61.
8. Li, D., and S. L. Friedman. 1999. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J. Gastroenterol. Hepatol. 14: 618.633.
9. Winau, F., C. Quack, A. Darmoise, and S. H. Kaufmann. 2008. Starring stellate cells in liver immunology. Curr. Opin. Immunol. 20: 68.74.
10. Jiang, G., H.-R. Yang, L. Wang, G. M. Wildey, J. Fung, S. Qian, and L. Lu. 2008. Hepatic stellate cells preferentially expand allogeneic CD4+CD25+FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation 86: 1492.1502.
11. Holt, A. P., E. L. Haughton, P. F. Lalor, A. Filer, C. D. Buckley, and D. H. Adams. 2009. Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology 136: 705.714.
12. Qian, S., A. J. Demetris, N. Murase, A. S. Rao, J. J. Fung, and T. E. Starzl. 1994. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 19: 916.924.
13. Chou, H.-S., C.-C. Hsieh, H.-R. Yang, L. Wang, Y. Arakawa, K. Brown, Q. Wu, F. Lin, M. Peters, J. J. Fung, et al. 2011. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology 53: 1007.1019.
14. Hsieh, C.-C., H.-S. Chou, H.-R. Yang, F. Lin, S. Bhatt, J. Qin, L. Wang, J. J. Fung, S. Qian, and L. Lu. 2013. The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood 121: 1760.1768.
15. Hochst, B., F. A. Schildberg, P. Sauerborn, Y. A. Gabel, H. Gevensleben, D. Goltz, L. C. Heukamp, A. T.urler, M. Ballmaier, F. Gieseke, et al. 2013. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion. J. Hepatol. 59: 528.535.
16. Pure, E., and C. A. Cuff. 2001. A crucial role for CD44 in inflammation. Trends Mol. Med. 7: 213.221.
17. Kusmartsev, S., and D. I. Gabrilovich. 2003. Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. J. Leukoc. Biol. 74: 186-196.
18. Xu, L., A. Y. Hui, E. Albanis, M. J. Arthur, S. M. Obyrne, W. S. Blaner, P. Mukherjee, S. L. Friedman, and F. J. Eng. 2005. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54: 142. 151.
19. Nakabayashi, H., K. Taketa, K. Miyano, T. Yamane, and J. Sato. 1982. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42: 3858.3863.
20. Mougiakakos, D., R. Jitschin, L. von Bahr, I. Poschke, R. Gary, B. Sundberg, A. Gerbitz, P. Ljungman, and K. Le Blanc. 2013. Immunosuppressive CD14+ HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation. Leukemia 27: 377.388.
21. Meda, L., C. Bonaiuto, P. Baron, L. Otvos, Jr., F. Rossi, and M. A. Cassatella. 1996. Priming of monocyte respiratory burst by b-amyloid fragment (25.35). Neurosci. Lett. 219: 91.94.
22. Hazen, S. L., R. Zhang, Z. Shen, W. Wu, E. A. Podrez, J. C. MacPherson, D. Schmitt, S. N. Mitra, C. Mukhopadhyay, Y. Chen, et al. 1999. Formation of nitric oxide.derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ. Res. 85: 950.958.
23. Yu, J., W. Du, F. Yan, Y. Wang, H. Li, S. Cao,W. Yu, C. Shen, J. Liu, and X. Ren. 2013. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. J. Immunol. 190: 3783.3797.
24. Lee, K. S., M. Buck, K. Houglum, and M. Chojkier. 1995. Activation of hepatic stellate cells by TGF a and collagen type I is mediated by oxidative stress through c-myb expression. J. Clin. Invest. 96: 2461.2468.
25. Yim, C. Y., J. B. Hibbs, Jr., J. R. McGregor, R. E. Galinsky, and W. E. Samlowski. 1994. Use of N-acetylcysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2. J. Immunol. 152: 5796.5805.
26. Irani, K. 2000. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 87: 179.183.
27. Goyal, P., N. Weissmann, F. Grimminger, C. Hegel, L. Bader, F. Rose, L. Fink, H. A. Ghofrani, R. T. Schermuly, H. H. H. Schmidt, et al. 2004. Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species. Free Radic. Biol. Med. 36: 1279.1288.
28. Bunt, S. K., L. Yang, P. Sinha, V. K. Clements, J. Leips, and S. Ostrand-Rosenberg. 2007. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 67: 10019.10026.
29. Schwarz, K. B. 1996. Oxidative stress during viral infection: a review. Free Radic. Biol. Med. 21: 641.649.
30. Chung-man Ho, J., S. Zheng, S. A. Comhair, C. Farver, and S. C. Erzurum. 2001. Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res. 61: 8578.8585.
31. Gottfried, E., M. Kreutz, and A. Mackensen. 2012. Tumor metabolism as modulator of immune response and tumor progression. Semin. Cancer Biol. 22: 335.341.
32. Kusmartsev, S., Y. Nefedova, D. Yoder, and D. I. Gabrilovich. 2004. Antigenspecific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. [Published erratum appears in 2004 J. Immunol. 172: 4647.] J. Immunol. 172: 989.999.
33. Bubici, C., S. Papa, K. Dean, and G. Franzoso. 2006. Mutual cross-talk between reactive oxygen species and nuclear factor-kB: molecular basis and biological significance. Oncogene 25: 6731.6748.
34. Phillips, D. C., K. J. Woollard, and H. R. Griffiths. 2003. The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. Br. J. Pharmacol. 138: 501.511.
35. Papatriantafyllou, M. 2013. Monocytes: the monocyte family tree. Nat. Rev. Immunol. 13: 549.549.
36. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656.661.
37. Komuro, I., T. Yasuda, A. Iwamoto, and K. S. Akagawa. 2005. Catalase plays a critical role in the CSF-independent survival of human macrophages via regulation of the expression of BCL-2 family. J. Biol. Chem. 280: 41137. 41145.
38. Tacke, R. S., H.-C. Lee, C. Goh, J. Courtney, S. J. Polyak, H. R. Rosen, and Y. S. Hahn. 2012. Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 55: 343.353.
39. Abe, T., T. Fukuhara, X. Wen, A. Ninomiya, K. Moriishi, Y. Maehara, O. Takeuchi, T. Kawai, S. Akira, and Y. Matsuura. 2012. CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is replicating, through an interaction with Toll-like receptor 2 and hyaluronan. J. Virol. 86: 6159. 6170.
40. Corzo, C. A., T. Condamine, L. Lu, M. J. Cotter, J.-I. Youn, P. Cheng, H.-I. Cho, E. Celis, D. G. Quiceno, T. Padhya, et al. 2010. HIF-1a regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 207: 2439.2453.
41. Niethammer, P., C. Grabher, A. T. Look, and T. J. Mitchison. 2009. A tissuescale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 459: 996.999.
42. Yoo, S. K., and A. Huttenlocher. 2009. Innate immunity: wounds burst H2O2 signals to leukocytes. Curr. Biol. 19: R553.R555.
43. Sporn, M. B., and K. T. Liby. 2012. NRF2 and cancer: the good, the bad and the importance of context. Nat. Rev. Cancer 12: 564.571.
44. Bellezza, I., A. L. Mierla, and A. Minelli. 2010. Nrf2 and NF-kB and their concerted modulation in cancer pathogenesis and progression. Cancers (Basel) 2: 483.497.
45. Wallace, D. C. 2012. Mitochondria and cancer. Nat. Rev. Cancer 12: 685.698.
46. Novo, E., and M. Parola. 2012. The role of redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 5(Suppl. 1 Proceedings of Fibroproliferative disorders: from biochemical analysis to targeted therapiesPetro E Petrides and David Brenner): S4.
47. Sies, H. 2014. Role of metabolic H2O2 generation: redox signaling and oxidative stress. J. Biol. Chem. 289: 8735.8741.